Pharmacia Hepar, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Pharmacia Hepar, Inc. makes
Pharmacia Hepar, Inc. makes the COAMATIC FACTOR VIII device, which is an in vitro diagnostic reagent used for measuring factor VIII activity in blood coagulation testing.
The COAMATIC FACTOR VIII device is classified as Class II and is listed in the FDA 510(k) registry; the company is based in the United States.
Catalogue
Coatest(R) Antithrombin Iii, Modification Ref K931420
Regimes: 510(k) Registry: 510(k)Coamatic Factor Viii Ref K943225
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Pharmacia Hepar, Inc. have in the registry?
The registry currently lists 2 devices for Pharmacia Hepar, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Pharmacia Hepar, Inc.'s devices?
Among its 2 most recently registered devices, Pharmacia Hepar, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Pharmacia Hepar, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Pharmacia Hepar, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Pharmacia Hepar, Inc. in the registry?
The most recently registered devices listed for Pharmacia Hepar, Inc. include COATEST(R) ANTITHROMBIN III, MODIFICATION and COAMATIC FACTOR VIII.